Novo Nordisk Loses Court Ruling Over Eli Lilly Obesity Drug Ads
Novo Nordisk A/S lost a bid in a U.S. court to temporarily block Eli Lilly & Co. from using advertisements that claim its drugs are more powerful, a setback to Novo as it battles to regain a larger share of …
Read more: https://www.claimsjournal.com/news/national/2026/1...
Scan with your phone
Scan with your phone